Agilon Health Inc. (AGL) Misses Q2 EPS by 74c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.79), $0.74 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $499 million versus the consensus estimate of $473.29 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• UBS Upgrades Bajaj Finance Ltd. (BAF:IN) to Neutral
• B. Riley previews Semi Cap Equipment sector ahead of Semicon West